Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

OrthoPediatrics Corp. operates as a medical device company. The Company designs, develops, and commercializes orthopedic implants and instruments to improve the lives of children with orthopedic conditions. OrthoPediatrics markets surgical systems for trauma and deformity, bone fractures, and reconstruction procedures. OrthoPediatrics serves orthopedic market globally.
Website: orthopediatrics.com



Growth: Good revenue growth rate 22.6%, there is slowdown compared to average historical growth rates 30.2%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is negative, -6.7%. On average the margin is improving steadily. Gross margin is high, +56.5%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.22 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -6.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 40.3% higher than minimum and 55.0% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.6x by EV / Sales multiple , the company can be 42.3% overvalued

Insiders: For the last 3 months insiders sold company shares on $0.5 mln (-0.076% of cap.)

Key Financials (Download financials)

Ticker: KIDS
Share price, USD:  (+3.2%)32.83
year average price 33.73  


year start price 46.39 2023-05-07

max close price 47.41 2023-06-15

min close price 23.40 2023-10-27

current price 32.83 2024-05-05
Common stocks: 22 762 689

Dividend Yield:  0.0%
Last revenue growth (y/y):  22.6%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  30.2%
Historical growth of EBITDA:  ---
EV / Sales: 4.5x
Margin (EBITDA LTM / Revenue): -6.7%
Fundamental value created in LTM:
Market Cap ($m): 747
Net Debt ($m): -70
EV (Enterprise Value): 677
Price to Book: 2.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-03-06Zacks Investment Research

OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

2024-03-06Zacks Investment Research

OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

2024-02-22GlobeNewsWire

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

2024-02-20Zacks Investment Research

OrthoPediatrics (KIDS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

2023-12-07Zacks Investment Research

OrthoPediatrics (KIDS) Introduces Unit for Non-Surgical Bracing

2023-11-06Zacks Investment Research

Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics

2023-10-17GlobeNewsWire

OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023

2023-10-17Zacks Investment Research

Strength Seen in OrthoPediatrics (KIDS): Can Its 8.1% Jump Turn into More Strength?

2023-08-01Seeking Alpha

OrthoPediatrics Corp. (KIDS) Q2 2023 Earnings Call Transcript

2023-07-31Zacks Investment Research

Compared to Estimates, OrthoPediatrics (KIDS) Q2 Earnings: A Look at Key Metrics
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol KIDS KIDS KIDS KIDS KIDS KIDS
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-08 2023-11-07 2023-08-01 2023-05-02 2023-03-01 2022-11-01
acceptedDate 2024-03-08 17:23:05 2023-11-07 16:47:48 2023-08-01 16:16:40 2023-05-02 15:46:03 2023-03-01 16:00:30 2022-11-01 16:48:10
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 38M 40M 40M 32M 31M 35M
costOfRevenue 16M 9M 10M 8M 10M 9M
grossProfit 21M 31M 30M 24M 21M 26M
grossProfitRatio 0.565 0.774 0.759 0.746 0.685 0.741
researchAndDevelopmentExpenses 3M 2M 3M 2M 2M 2M
generalAndAdministrativeExpenses 20M 19M 20M 18M 17M 15M
sellingAndMarketingExpenses 12M 14M 13M 12M 11M 12M
sellingGeneralAndAdministrativeExpenses 27M 32M 33M 30M 27M 27M
otherExpenses 854 000 787 000 289 000 331 000 -129 000 0
operatingExpenses 29M 34M 36M 32M 30M 29M
costAndExpenses 46M 43M 45M 40M 39M 38M
interestIncome 303 000 21 000 294 000 0 0 0
interestExpense -303 000 21 000 294 000 566 000 -61 000 708 000
depreciationAndAmortization 5M 4M 4M 3M 3M 22M
ebitda -3M 2M -1M -5M -5M 18M
ebitdaratio -0.069 0.038 -0.031 -0.171 -0.159 0.526
operatingIncome -8M -5M -6M -9M -8M -3M
operatingIncomeRatio -0.214 -0.113 -0.141 -0.272 -0.268 -0.096
totalOtherIncomeExpensesNet 1M -198 000 3M 1M 412 000 18M
incomeBeforeTax -7M -4M -3M -7M -8M 14M
incomeBeforeTaxRatio -0.184 -0.094 -0.083 -0.234 -0.255 0.412
incomeTaxExpense -212 000 849 000 -401 000 -574 000 -48 000 -4M
netIncome -7M -5M -3M -7M -8M 19M
netIncomeRatio -0.178 -0.115 -0.073 -0.215 -0.253 0.530
eps -0.290 -0.200 -0.130 -0.300 -0.350 0.880
epsdiluted -0.290 -0.200 -0.130 -0.300 -0.350 0.870
weightedAverageShsOut 23M 23M 23M 23M 22M 21M
weightedAverageShsOutDil 23M 23M 23M 23M 22M 21M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol KIDS KIDS KIDS KIDS KIDS KIDS
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-08 2023-11-07 2023-08-01 2023-05-02 2023-03-01 2022-11-01
acceptedDate 2024-03-08 17:23:05 2023-11-07 16:47:48 2023-08-01 16:16:40 2023-05-02 15:46:03 2023-03-01 16:00:30 2022-11-01 16:48:10
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 33M 11M 10M 35M 9M 35M
shortTermInvestments 49M 72M 83M 73M 109M 85M
cashAndShortTermInvestments 82M 82M 93M 108M 118M 120M
netReceivables 35M 38M 34M 27M 25M 26M
inventory 106M 101M 91M 85M 78M 74M
otherCurrentAssets 4M 4M 4M 4M 4M 4M
totalCurrentAssets 226M 226M 223M 225M 227M 225M
propertyPlantEquipmentNet 41M 40M 40M 37M 34M 36M
goodwill 84M 81M 83M 84M 87M 88M
intangibleAssets 85M 85M 88M 80M 80M 81M
goodwillAndIntangibleAssets 168M 165M 171M 164M 167M 169M
longTermInvestments 2M -5M -6M 0 0 0
taxAssets 11M 5M 6M 6M 0 0
otherNonCurrentAssets 1M 621 000 614 000 -6M 0 0
totalNonCurrentAssets 223M 206M 212M 201M 201M 205M
otherAssets 0 0 0 0 0 0
totalAssets 450M 432M 435M 426M 428M 430M
accountPayables 13M 23M 21M 17M 11M 11M
shortTermDebt 10M 150 000 148 000 146 000 144 000 143 000
taxPayables 0 0 0 0 0 0
deferredRevenue 0 19M 18M 0 6M 0
otherCurrentLiabilities 19M 7M 5M 18M 14M 18M
totalCurrentLiabilities 42M 48M 44M 35M 31M 29M
longTermDebt 13M 650 000 688 000 725 000 763 000 799 000
deferredRevenueNonCurrent -10M 3M 3M 0 0 0
deferredTaxLiabilitiesNonCurrent 16M 5M 6M 6M 6M 5M
otherNonCurrentLiabilities 11M 557 000 568 000 11M 11M 7M
totalNonCurrentLiabilities 31M 10M 10M 18M 18M 18M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 1M 434 000 0 0 0 0
totalLiabilities 73M 58M 55M 53M 49M 47M
preferredStock 0 0 0 0 0 0
commonStock 6000.000 6000.000 6000.000 6000.000 6000.000 6000.000
retainedEarnings -198M -191M -186M -184M -177M -169M
accumulatedOtherComprehensiveIncomeLoss -6M -12M -8M -6M -5M -7M
othertotalStockholdersEquity 580M 578M 575M 563M 561M 559M
totalStockholdersEquity 377M 374M 380M 373M 379M 383M
totalEquity 377M 374M 380M 373M 379M 383M
totalLiabilitiesAndStockholdersEquity 450M 432M 435M 426M 428M 430M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 450M 432M 435M 426M 428M 430M
totalInvestments 51M 72M 83M 73M 109M 85M
totalDebt 24M 800 000 836 000 871 000 907 000 942 000
netDebt -9M -10M -9M -34M -8M -34M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol KIDS KIDS KIDS KIDS KIDS KIDS
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-08 2023-11-07 2023-08-01 2023-05-02 2023-03-01 2022-11-01
acceptedDate 2024-03-08 17:23:05 2023-11-07 16:47:48 2023-08-01 16:16:40 2023-05-02 15:46:03 2023-03-01 16:00:30 2022-11-01 16:48:10
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome -7M -5M -3M -7M -8M 19M
depreciationAndAmortization 5M 4M 4M 4M 4M 3M
deferredIncomeTax -264 000 76 000 -401 000 -574 000 -228 000 -4M
stockBasedCompensation 3M 2M 3M 2M 2M 2M
changeInWorkingCapital -9M -12M -7M -5M -387 000 -6M
accountsReceivables 3M -4M -7M -2M 2M 1M
inventory -4M -10M -6M -6M -2M -4M
accountsPayables -10M 2M 4M 6M 180 000 -6M
otherWorkingCapital 2M 431 000 2M -2M -25 000 2M
otherNonCashItems -18 000 1M -2M -289 000 -99 000 -19M
netCashProvidedByOperatingActivities -8M -9M -4M -6M -3M -6M
investmentsInPropertyPlantAndEquipment -6M -2M -6M -5M 523 000 -1M
acquisitionsNet 546 000 -546 000 -3M 0 32M -32M
purchasesOfInvestments 0 -4M -45M 0 -25M 0
salesMaturitiesOfInvestments 24M 17M 35M 37M 1M 14M
otherInvestingActivites -546 000 13M 0 0 -32M -85M
netCashUsedForInvestingActivites 18M 10M -18M 32M -23M -104M
debtRepayment -9M -36 000 -35 000 -36 000 -35 000 -31M
commonStockIssued 0 139M 0 0 31M 108M
commonStockRepurchased 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites 19M -139M -2M 0 -31M 31M
netCashUsedProvidedByFinancingActivities 9M -15 000 -2M -36 000 -35 000 108M
effectOfForexChangesOnCash 1M -61 000 -197 000 -138 000 193 000 26 000
netChangeInCash 21M 923 000 -25M 26M -26M -2M
cashAtEndOfPeriod 33M 12M 11M 36M 10M 37M
cashAtBeginningOfPeriod 12M 11M 36M 10M 37M 39M
operatingCashFlow -8M -9M -4M -6M -3M -6M
capitalExpenditure -6M -2M -6M -5M 523 000 -1M
freeCashFlow -13M -11M -10M -11M -3M -7M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-03-07 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-01 ET (fiscal 2023 q2)
2023 q1
2023-05-02 ET (fiscal 2023 q1)
2022 q4
2023-03-01 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-07 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-03-06 21:05 ET
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
2024-03-04 21:05 ET
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
2024-02-28 13:05 ET
OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
2024-02-22 21:24 ET
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
2024-01-08 13:05 ET
OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
2024-01-08 13:00 ET
OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics
2023-12-06 13:05 ET
OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division
2023-12-04 13:05 ET
OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)
2023-11-09 21:05 ET
OrthoPediatrics Corp. to Participate in Upcoming November Conferences
2023-11-06 21:05 ET
OrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results
2023-11-06 13:05 ET
OrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical
2023-11-01 13:17 ET
OrthoPediatrics Corp. Launches MP+ Bar for Clubfoot
2023-10-19 12:05 ET
OrthoPediatrics Corp. Launches Pediatric Nailing Platform | Tibia
2023-10-17 20:05 ET
OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023
2023-10-12 12:05 ET
OrthoPediatrics Joins Alliance for Pediatric Device Innovation
2023-10-10 12:05 ET
OrthoPediatrics Corp. Launches DF2 Brace®
2023-09-25 12:05 ET
OrthoPediatrics was a Gold Level Sponsor of the Scoliosis Research Society 58th Annual Meeting
2023-09-14 12:05 ET
OrthoPediatrics Corp. to Participate at the Gilmartin Group Emerging Growth Company Showcase
2023-09-11 20:05 ET
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | Tibia
2023-07-31 20:05 ET
OrthoPediatrics Corp. Reports Second Quarter 2023 Financial Results
2023-07-18 12:05 ET
OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023
2023-06-27 12:07 ET
OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System
2023-06-15 12:05 ET
OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors
2023-05-04 20:05 ET
OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System
2023-05-01 20:05 ET
OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
2023-05-01 12:00 ET
OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting
2023-04-20 20:05 ET
OrthoPediatrics Corp. Announces Launch of RESPONSE™ 5.5/6.0 Cannulated Screw System
2023-04-17 12:05 ET
OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 2, 2023
2023-04-03 20:05 ET
OrthoPediatrics Corp. to Participate at the 22nd Annual Needham Virtual Healthcare Conference
2023-03-31 20:05 ET
OrthoPediatrics Corp. Leading Sponsorship at Annual EPOS Meeting
2023-03-06 13:00 ET
OrthoPediatrics Corp. Named One of the 2023 Best Places to Work in Indiana
2023-02-28 21:05 ET
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results
2023-02-14 13:05 ET
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
2023-02-01 13:05 ET
OrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report
2023-01-09 21:03 ET
OrthoPediatrics Corp. Announces Preliminary Unaudited Net Revenue for the Fourth Quarter & Full Year 2022, Provides Financial Outlook for 2023
2023-01-06 13:05 ET
OrthoPediatrics Corp. Establishes Direct Sales Organization in Germany
2022-12-05 21:05 ET
OrthoPediatrics Corp. to Host Educational and Networking Events at 18th Annual International Pediatric Orthopaedic Symposium (IPOS)
2022-11-04 12:05 ET
OrthoPediatrics to Participate in Upcoming November Conferences
2022-10-31 20:03 ET
OrthoPediatrics Corp. Reports Third Quarter 2022 Financial Results and Updates 2022 Revenue Guidance
2022-10-20 12:05 ET
OrthoPediatrics Corp. Announces Appointment of Jimmy D. McDonald to Board of Directors
2022-10-18 12:00 ET
OrthoPediatrics Corp. to Report Third Quarter 2022 Financial Results on November 1, 2022
2022-08-18 20:02 ET
OrthoPediatrics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
2022-08-15 20:02 ET
OrthoPediatrics Corp. Announces Closing of its Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
2022-08-11 12:00 ET
OrthoPediatrics Corp. Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
2022-08-10 20:01 ET
OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants
2022-08-03 20:02 ET
OrthoPediatrics Corp. Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
2022-07-21 12:00 ET
OrthoPediatrics Corp. to Report Second Quarter 2022 Financial Results on August 4, 2022
2022-07-13 12:00 ET
OrthoPediatrics Corp. Announces Distribution Agreement with 3D-Side
2022-07-05 12:00 ET
OrthoPediatrics Corp. Completes Acquisition of Pega Medical
2022-06-14 12:00 ET
OrthoPediatrics Corp. Announces Deal to Acquire Pega Medical
2022-05-24 12:00 ET
OrthoPediatrics to Participate in The JMP Securities Life Sciences Conference
2022-05-10 12:00 ET
OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2022 POSNA Meeting
2022-05-04 20:03 ET
OrthoPediatrics Corp. Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
2022-04-18 20:03 ET
OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022
2022-04-12 12:00 ET
OrthoPediatrics Spotlights Award-Winning ApiFix® Technology at IMAST
2022-04-06 12:00 ET
OrthoPediatrics’ ApiFix® System Selected as 2022 MDEA Finalist
2022-04-04 12:00 ET
OrthoPediatrics Corp. Announces Acquisition of MD Orthopaedics
2022-03-31 12:00 ET
OrthoPediatrics to Participate in the 21st Annual Needham Virtual Healthcare Conference
2022-03-24 12:00 ET
OrthoPediatrics Corp. Launches PediFlex™ Advanced Interlock Clamp System
2022-03-02 21:03 ET
OrthoPediatrics Corp. Reports Fourth Quarter and Record Full Year 2021 Financial Results
2022-03-01 13:00 ET
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 7th Annual International Children’s Spine Symposium (ICSS)
2022-02-25 13:00 ET
OrthoPediatrics Corp. Named One of the 2022 Best Places to Work in Indiana
2022-02-23 13:00 ET
OrthoPediatrics Corp. Celebrates 1,000th Case with FIREFLY® Pedicle Screw Navigation Guides
2022-02-01 13:00 ET
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
2022-01-10 12:01 ET
OrthoPediatrics Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Year 2021
2021-12-28 11:55 ET
Telos Partners LLC Welcomes Industry Veteran Scott Day as Senior VP and General Manager to Accelerate Growth Strategy
2021-12-13 12:00 ET
OrthoPediatrics Corp. Continued Double-Diamond Support of International Pediatric Orthopaedic Symposium (IPOS)
2021-11-22 21:02 ET
OrthoPediatrics to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
2021-11-03 20:01 ET
OrthoPediatrics Corp. Reports Third Quarter 2021 Financial Results
2021-10-26 20:05 ET
OrthoPediatrics to Participate in the Stifel 2021 Virtual Healthcare Conference
2021-10-18 20:03 ET
OrthoPediatrics Corp. Recognized in COVID Stops Here Campaign
2021-10-13 20:04 ET
OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for the Third Quarter 2021 and Reiterates 2021 Revenue Guidance
2021-10-04 20:03 ET
OrthoPediatrics Corp. Continues Support of Autumn Surgical Society Meetings
2021-09-09 20:03 ET
OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications
2021-08-04 20:01 ET
OrthoPediatrics Corp. Reports Second Quarter 2021 Financial Results
2021-08-04 11:00 ET
OrthoPediatrics Corp. and Mighty Oak Medical Extend Exclusive Partnership for FIREFLY Technology in Pediatric Orthopedics
2021-07-29 20:02 ET
OrthoPediatrics Corp. Maintains its Diamond Sponsorship for 31st Annual Baltimore Limb Deformity Course (“BLDC”)
2021-07-22 12:00 ET
OrthoPediatrics Corp. to Report Second Quarter 2021 Financial Results on August 5, 2021
2021-06-10 11:04 ET
OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw System
2021-06-09 20:04 ET
OrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences Conference
2021-06-03 11:00 ET
OrthoPediatrics Corp. Completes Senior Leadership Transition with Appointment of David Bailey as Chief Executive Officer
2021-05-28 12:00 ET
OrthoPediatrics Corp. Launches RESPONSE™ Neuromuscular Scoliosis System
2021-05-17 12:30 ET
OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2021 POSNA Meeting
2021-05-05 20:05 ET
OrthoPediatrics Corp. Reports First Quarter 2021 Financial Results
2021-04-22 12:30 ET
OrthoPediatrics Corp. to Participate in the 7th Annual Truist Securities 2021 Life Sciences Summit
2021-04-21 20:05 ET
OrthoPediatrics Corp. to Report First Quarter 2021 Financial Results on May 5, 2021
2021-03-31 20:05 ET
OrthoPediatrics Corp. to Participate in the 20th Annual Needham Virtual Healthcare Conference
2021-03-23 12:30 ET
OrthoPediatrics Surpasses Milestones of 500 Scoliosis Correction Cases Worldwide and Nine-Years of Clinical Experience with the ApiFix Procedure
2021-03-10 21:05 ET
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2020 Financial Results
2021-03-04 16:20 ET
OrthoPediatrics Corp. Crosses Milestone Treating 200,000 Children with Orthopedic Conditions
2021-03-03 13:30 ET
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021
2021-02-24 13:30 ET
2021 Best Places to Work in Indiana
2021-02-18 13:30 ET
OrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal Deformity Correction System for Treating AIS
2021-02-11 13:30 ET
OrthoPediatrics Corp. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
2021-01-22 13:30 ET
OrthoPediatrics Corp. Introduces Orthex in Australia
2021-01-19 21:05 ET
OrthoPediatrics Corp. Introduces Expanded Product Portfolio in Canada
2021-01-15 13:30 ET
OrthoPediatrics Corp. Expands its Agent Network in Three Strategic European Countries
2021-01-11 21:05 ET
OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2020
2021-01-05 13:30 ET
OrthoPediatrics Corp. Launches Sterile Implants for PNP|FEMUR System
2021-01-04 13:30 ET
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Growth Conference
2020-12-29 13:30 ET
OrthoPediatrics Corp. Announces First PNP|FEMUR Case Performed in the United Kingdom
2020-12-21 13:30 ET
OrthoPediatrics Corp. Announces International Expansion in the United Kingdom
2020-12-03 14:00 ET
OrthoPediatrics Named 2020 Corporate Champion of the Year By World Pediatric Project
2020-11-04 21:05 ET
OrthoPediatrics Corp. Reports Third Quarter 2020 Financial Results
2020-10-29 18:17 ET
Telos Partners LLC Announces the Addition of Erik Waldorff, PhD as Director of Science & Innovation to Fortify Its Expertise in the Musculoskeletal Device and Biotechnology Industry
2020-10-29 12:00 ET
OrthoPediatrics Corp. to Present at Four Upcoming Investor Conferences in November and December
2020-10-21 20:05 ET
OrthoPediatrics Corp. to Report Third Quarter 2020 Financial Results on November 4, 2020
2020-10-08 13:00 ET
OrthoPediatrics Corp. to Support the 3rd Annual PediOrtho WEST Resident Education Course in October 2020
2020-09-15 21:54 ET
Telos Partners LLC Appoints Jason Inzana, PhD to General Manager in Next Phase of Growth Strategy
2020-09-09 13:00 ET
OrthoPediatrics Corp. to Sponsor Two Medical Meetings in September 2020
2020-09-08 13:00 ET
OrthoPediatrics Corp. to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference
2020-09-03 13:00 ET
OrthoPediatrics Corp. Announces 1,000th Procedure Utilizing its Innovative Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”) System, the First Pediatric-Specific Solution Optimized to Treat Fractures and Deformities
2020-08-24 13:00 ET
OrthoPediatrics Corp. Maintains its Diamond Sponsorship for Virtual 30th Annual Baltimore Limb Deformity Course (“BLDC”)
2020-08-10 13:00 ET
OrthoPediatrics Corp. to Participate in the 5th Annual Needham Virtual Med Tech 1x1 Conference
2020-08-05 20:23 ET
OrthoPediatrics Corp. Reports Second Quarter 2020 Financial Results
2020-08-03 13:00 ET
OrthoPediatrics Corp. Achieves 500th Case with FIREFLY® Pedicle Screw Navigation Guides
2020-07-23 20:05 ET
OrthoPediatrics Corp. to Report Second Quarter 2020 Financial Results on August 5, 2020
2020-06-22 20:06 ET
OrthoPediatrics Corp. Announces Closing of Offering of Common Stock
2020-06-18 12:00 ET
OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock
2020-06-17 20:01 ET
OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock
2020-06-10 12:30 ET
OrthoPediatrics Corp. Commences Initial U.S. Launch of ApiFix’s FDA-Approved Spinal Deformity Correction System
2020-05-13 13:00 ET
OrthoPediatrics Corp. to Continue Sponsorship for 2020 POSNA Annual Meeting
2020-05-05 20:18 ET
OrthoPediatrics Corp. Reports First Quarter 2020 Financial Results
2020-04-29 20:05 ET
OrthoPediatrics Corp. to Participate in the 6th Annual SunTrust Robinson Humphrey Life Sciences Summit
2020-04-21 13:00 ET
OrthoPediatrics Corp. to Report First Quarter 2020 Financial Results on May 5, 2020
2020-04-01 20:05 ET
OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology
2020-03-31 13:00 ET
OrthoPediatrics Corp. Receives FDA 510(k) Clearance and Expanded Neuromuscular Indications for its RESPONSE™ Scoliosis System
2020-03-30 12:00 ET
OrthoPediatrics Corp. Provides COVID-19 Business Update
2020-03-09 20:05 ET
OrthoPediatrics Corp. Announces U.S. Launch of Large Fragment Cannulated Screw System
2020-03-04 21:05 ET
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2019 Financial Results
2020-03-03 21:05 ET
OrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Italy
2020-03-02 13:30 ET
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 6th Annual International Children’s Spine Symposium (ICSS)
2020-02-26 13:30 ET
OrthoPediatrics Corp. Continues to be Honored as One of the Best Place to Work in Indiana
2020-02-18 14:00 ET
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2019 Financial Results on March 4, 2020
2020-01-13 13:00 ET
OrthoPediatrics Corp. Reports Preliminary Unaudited Revenue for Fourth Quarter and Record Setting Full Year 2019
2020-01-06 13:30 ET
OrthoPediatrics Corp. Announces Divestiture of the Vilex Adult Business
2019-12-20 14:00 ET
OrthoPediatrics Corp. Announces U.S. Launch of QuickPack™
2019-12-17 14:00 ET
OrthoPediatrics Corp. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
2019-12-11 14:00 ET
OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock
2019-12-10 21:27 ET
OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock
2019-11-20 13:00 ET
OrthoPediatrics Corp. to Sponsor the Annual International Pediatric Orthopaedic Symposium (IPOS)
2019-11-15 14:00 ET
OrthoPediatrics Corp. Announces U.S. Launch of PediFoot Deformity Correction System
2019-11-11 14:00 ET
OrthoPediatrics Corp. to Present at Two Upcoming Investor Conferences
2019-11-07 21:36 ET
OrthoPediatrics Corp. Reports Third Quarter 2019 Financial Results
2019-10-23 13:00 ET
OrthoPediatrics Corp. to Report Third Quarter 2019 Financial Results on November 7, 2019
2019-09-25 13:00 ET
OrthoPediatrics Corp. to Participate at the Cantor Fitzgerald Global Healthcare Conference
2019-09-16 13:00 ET
OrthoPediatrics Corp. to Sponsor Three Medical Meetings in September 2019
2019-09-09 20:05 ET
OrthoPediatrics Corp. Announces U.S. Launch of Next Generation Cannulated Screw Systems
2018-12-31 12:20 ET
Report: Exploring Fundamental Drivers Behind Bristol-Myers Squibb, Ascena Retail Group, OrthoPediatrics, Star Bulk Carriers, Leidos, and ADOMANI — New Horizons, Emerging Trends, and Upcoming Developments
ET
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
ET
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
ET
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
ET
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis

SEC forms

Show financial reports only

SEC form 10
2024-03-08 17:23 ET
OrthoPediatrics published news for 2023 q4
SEC form 10
2024-03-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-03-06 16:34 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-03-06 16:34 ET
OrthoPediatrics reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 10
2023-11-07 16:47 ET
OrthoPediatrics published news for 2023 q3
SEC form 10
2023-11-07 00:00 ET
OrthoPediatrics published news for 2023 q3
SEC form 8
2023-11-06 16:11 ET
OrthoPediatrics reported for 2023 q3
SEC form 10
2023-08-01 16:16 ET
OrthoPediatrics published news for 2023 q2
SEC form 10
2023-08-01 00:00 ET
OrthoPediatrics published news for 2023 q2
SEC form 6
2023-07-31 16:13 ET
OrthoPediatrics reported for 2023 q2
SEC form 8
2023-07-31 00:00 ET
OrthoPediatrics published news for 2023 q2
SEC form 6
2023-06-16 13:57 ET
OrthoPediatrics published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
OrthoPediatrics published news for 2023 q1
SEC form 8
2023-05-01 00:00 ET
OrthoPediatrics published news for 2023 q1
SEC form 6
2023-03-08 07:27 ET
OrthoPediatrics published news for 2022 q4
SEC form 10
2023-03-01 16:00 ET
OrthoPediatrics reported for 2022 q4
SEC form 10
2023-03-01 00:00 ET
OrthoPediatrics reported for 2022 q4
SEC form 6
2023-02-28 16:18 ET
OrthoPediatrics published news for 2022 q4
SEC form 8
2023-02-28 00:00 ET
OrthoPediatrics reported for 2022 q4
SEC form 6
2023-01-09 17:29 ET
OrthoPediatrics published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
OrthoPediatrics published news for 2022 q4
SEC form 10
2022-11-01 16:48 ET
OrthoPediatrics reported for 2022 q3
SEC form 6
2022-11-01 11:47 ET
OrthoPediatrics published news for 2022 q3
SEC form 10
2022-11-01 00:00 ET
OrthoPediatrics reported for 2022 q3
SEC form 6
2022-10-31 16:15 ET
OrthoPediatrics published news for 2022 q3
SEC form 8
2022-10-31 00:00 ET
OrthoPediatrics reported for 2022 q3
SEC form 6
2022-10-20 09:15 ET
OrthoPediatrics published news for 2022 q3
SEC form 6
2022-08-11 19:50 ET
OrthoPediatrics published news for 2022 q2
SEC form 10
2022-08-04 13:08 ET
OrthoPediatrics reported for 2022 q2
SEC form 6
2022-08-04 09:54 ET
OrthoPediatrics published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
OrthoPediatrics reported for 2022 q2
SEC form 6
2022-08-03 16:14 ET
OrthoPediatrics published news for 2022 q2
SEC form 8
2022-08-03 00:00 ET
OrthoPediatrics reported for 2022 q2
SEC form 6
2022-06-15 11:54 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-06-14 08:07 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-06-01 12:26 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-05-10 10:34 ET
OrthoPediatrics published news for 2022 q1
SEC form 10
2022-05-05 16:25 ET
OrthoPediatrics reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
OrthoPediatrics reported for 2022 q1
SEC form 6
2022-05-04 16:13 ET
OrthoPediatrics published news for 2022 q1
SEC form 8
2022-05-04 00:00 ET
OrthoPediatrics reported for 2022 q1
SEC form 6
2022-04-15 11:16 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-04-04 08:00 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-03-04 11:51 ET
OrthoPediatrics published news for 2021 q4
SEC form 10
2022-03-03 14:56 ET
OrthoPediatrics published news for 2021 q4
SEC form 10
2022-03-03 00:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2022-03-02 16:14 ET
OrthoPediatrics published news for 2021 q4
SEC form 8
2022-03-02 00:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2022-01-10 10:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2022-01-06 15:33 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2021-11-08 11:29 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-11-04 16:23 ET
OrthoPediatrics published news for 2021 q3
SEC form 10
2021-11-04 15:36 ET
OrthoPediatrics published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-11-03 16:12 ET
OrthoPediatrics published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-10-13 16:10 ET
OrthoPediatrics published news for 2021 q3
SEC form 8
2021-10-13 00:00 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-08-12 13:04 ET
OrthoPediatrics published news for 2021 q2
SEC form 10
2021-08-05 15:40 ET
OrthoPediatrics published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
OrthoPediatrics published news for 2021 q2
SEC form 6
2021-08-04 16:41 ET
OrthoPediatrics published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
OrthoPediatrics published news for 2021 q2
SEC form 6
2021-06-03 08:23 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-05-28 08:46 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-05-10 07:30 ET
OrthoPediatrics published news for 2021 q1
SEC form 10
2021-05-06 11:30 ET
OrthoPediatrics published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-05-05 16:32 ET
OrthoPediatrics published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-04-16 08:36 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-03-30 13:38 ET
OrthoPediatrics published news for 2020 q4
SEC form 10
2021-03-11 15:50 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-03-10 16:38 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-15 09:20 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-12 09:01 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-11 16:39 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-05 08:49 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2020-12-30 20:00 ET
OrthoPediatrics published news for 2020 q3
SEC form 6
2020-12-14 16:10 ET
OrthoPediatrics published news for 2020 q3
SEC form 6
2020-11-10 16:43 ET
OrthoPediatrics published news for 2020 q3
SEC form 10
2020-11-05 16:47 ET
OrthoPediatrics published news for 2020 q3
SEC form 6
2020-11-04 17:12 ET
OrthoPediatrics published news for 2020 q3